DBI 357 Super Magnum Caffeine Tablets Recalled for cGMP Deviations
Ultra Seal Corporation is recalling DBI 357 Super Magnum Quick Energy Stimulant caffeine tablets distributed nationwide due to current good manufacturing practice (cGMP) deviations. The recall includes 36-count, 100-count, and 500-count bottles, as well as 3-count packets.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. The hazard is a cGMP deviation—a manufacturing practice deficiency rather than a confirmed contamination, illness, or injury. No illnesses or injuries are reported in the source text, and the recall is voluntary and precautionary in nature.
Plain-English summary
Ultra Seal Corporation is recalling DBI 357 Super Magnum Quick Energy Stimulant tablets containing 200 mg of caffeine. The product is packaged in four formats: 36-count bottles, 100-count bottles, 500-count bottles, and 3-count packets. A total of 147,528 bottles (36-count), 2,451 bottles (100-count), 2,492 bottles (500-count), and 573,696 packets (3-count) were distributed nationwide in the United States.
The recall was initiated by the manufacturer due to cGMP deviations—violations of current good manufacturing practice regulations. The firm voluntarily initiated this recall by letter on January 24, 2022, and the FDA classified it as a Class II recall on January 31, 2022.
Affected lot numbers and expiration dates are as follows: for 36-count bottles—Lot C19065 (Exp. 03/2022), F19081 (Exp. 06/2022), and 19H083 (Exp. 08/2022); for 100-count bottles—Lot H19083 and 1H9083 (Exp. 08/2022); for 500-count bottles—Lot 19F081 (Exp. 06/2022) and 19083H (Exp. 08/2022); and for 3-count packets—Lot 19C065 (Exp. 03/2022), 19081F (Exp. 06/2022). Consumers in possession of affected product should cease use and consult with a healthcare provider or pharmacist for guidance.
The recalled product
- Product
- DBI 357 Super Magnum Quick Energy Stimulant (caffeine 200mg) tablets, packaged in a) 36-count bottles, b) 100-count bottles, c) 500-count bottles, and d) 3-count packets, Marketed by: DBI Distribution A Division of King Richard Promotions, Inc. P.O. Box 78546, Indianapolis, IN 46
- Manufacturer
- Ultra Seal Corporation
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot #: a) C19065
- Exp. Date 03/2022
- F19081
- Exp. Date 06/2022
- 19H083
- Exp. Date 08/2022
- b) H19083
- 1H9083
- c) 19F081
- 19083H
- d) 19C065
- 19081F
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27